Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS‐CoV‐2

por Petrak, Russell M., Skorodin, Nathan C., Van Hise, Nicholas W., Fliegelman, Robert M., Pinsky, Jonathan, Didwania, Vishal, Anderson, Michael, Diaz, Melina, Shah, Kairav, Chundi, Vishnu V., Hines, David W., Harting, Brian P., Sidwha, Kamo, Yu, Brian, Brune, Paul, Owaisi, Anjum, Beezhold, David, Kent, Joseph, Vais, Dana, Han, Alice, Gowda, Neethi, Sahgal, Nishi, Silverman, Jan, Stake, Jonathan, Nepomuceno, Jenie, Heddurshetti, Renuka
Publicado 2021